Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Spectrum Health and Beaumont Health to Launch New Health System

Spectrum Health and Beaumont Health to Launch New Health System

Beaumont Health and Spectrum Health are moving forward to create a new health system that is For Michigan, By Michigan™. The new system, which will be temporarily known as BHSH System, will launch Feb. 1, 2022. Both organizations have provided the applicable regulatory agencies with all requested information and may now proceed to launch their new health system.

Both organizations express deep gratitude for the ongoing efforts of physicians, nurses and all of the team members who continue to care for each other and their communities after nearly two years of the pandemic. They have worked tirelessly to provide exemplary health care and coverage, and they continue to do so during this current surge.

“We are grateful for all of our physicians, nurses and team members. Their compassion, expertise and dedication have saved many lives during this pandemic,” Tina Freese Decker, President & CEO of Spectrum Health, and future BHSH System President & CEO, said. “As we launch our new health system, we have a bold goal to transform health and are thrilled to unite our two great organizations. Together, we will leverage our complementary strengths to innovate and make a positive impact for our communities and their health. We look forward to working with our physicians, team members, patients, health plan members and partners across our state to provide health care and coverage that is accessible, affordable, equitable and exceptional.”

Beaumont Health Board Chair and incoming BHSH System Board Chair Julie Fream added, “Our focus, as we launch our new health system, is to continue to provide excellent health care and coverage in our communities. We look forward to continuing to partner with our patients, team members and health plan members as we build a new organization designed to improve the health of the communities we serve.”

Beaumont Health and Spectrum Health also announced the board of directors and system leadership team for the new combined health system.

The new organization will conduct internal and national searches to fill the open and interim roles, including the national search underway for the president of BHSH Beaumont Health. As announced last year, John Fox, Beaumont Health’s current president, plans to leave the organization. His last day will be Feb. 4.

“I am very proud of our Beaumont team members for their many accomplishments, and I’m especially proud of the compassionate, extraordinary care they have provided for our patients throughout this long pandemic. I’m confident BHSH System will become one of the best health care systems in the nation,” said John Fox, current Beaumont President & CEO.

Sean Welsh, current Spectrum Health System board chair and incoming BHSH System board vice chair, said, “The tremendous talent within these two organizations will be a beacon for others who share this vision for a new health system and the positive change it will create.”

While Spectrum Health and Beaumont Health create this new health system, patients and health plan members are encouraged to access care in the same ways they currently do. All patients will continue to have access to their same sites of care, physicians and health providers, and insurance plans.

For more updates and information about the board of directors and leadership teams for each division, visit ForMichiganByMichigan.org.
About BHSH System

Forming from two leading health systems in Michigan (Beaumont Health and Spectrum Health), BHSH System will be a not-for-profit health system that provides care and coverage with an exceptional team of 64,000+ dedicated people – including more than 11,500 physicians and advanced practice providers and more than 15,000 nurses offering services in 22 hospitals, 300+ outpatient locations and several post-acute facilities – and Priority Health, a provider-sponsored health plan serving over 1.2 million members across the state of Michigan. Through experience, innovation and collaboration, we will build a system designed to meet the needs of the people we serve through care and coverage that is accessible, affordable, equitable and exceptional.

About Beaumont Health

Beaumont Health is Michigan’s largest health care system and is most preferred for health care in Southeast Michigan, according to NRC Health survey data. The not-for-profit organization’s more than 33,000 employees share a mission to provide compassionate, extraordinary care every day. The system includes eight hospitals with 3,375 beds, 155 outpatient sites, nearly 5,000 affiliated physicians, 1,800 advanced practice providers, 9,000 nurses and 2,000 volunteers. Beaumont’s total annual net patient revenue is $4.6 billion. In 2019, the health system had 179,600 inpatient discharges, 17,600 births and 577,000 emergency visits.

About Spectrum Health

Spectrum Health is a $8.3 billion, not-for-profit health system that provides care and coverage, comprising 31,000+ team members, 14 hospitals (including Helen DeVos Children’s Hospital), a robust network of care facilities, teams of nationally recognized doctors and providers, and the nation’s third-largest provider-sponsored health plan, Priority Health, currently serving over 1.2 million members across the state of Michigan. Spectrum Health has a legacy of strong community partnerships, philanthropy and transparency. We are reimagining a better, more equitable model of health and wellness.

CGCH is among the first hospitals in the United States to use the innovative system

CGCH is among the first hospitals in the United States to use the innovative system

Carilion Giles Community Hospital (CGCH) is among the first hospitals in the United States to install GE Healthcare’s next-generation advanced x-ray system, AMX Navigate. CGCH staff are using the portable, power-assisted x-ray system today after weeks of staff training.

GE Healthcare designed AMX Navigate to help x-ray technologists reduce the stress and strain of their jobs. The company conducted clinical research on portable x-ray systems, leading to a new design focused on improving user experience. The system’s design incorporates a unique power-assisted Free Motion telescoping column that reduces the physical effort required for exams by around 70% using the system’s main console.

“As x-ray technologists, my colleagues and I experience the strain from performing multiple x-rays every day,” said Jennifer Collins, imaging services manager for CGCH. “Carilion is excited about AMX Navigate’s design reducing the effort required for system set-up and processing x-rays. The system’s smaller footprint makes it easier to move, reduces exam time, and allows us to quickly provide high-quality x-ray images in caring for the patients we serve.”

AMX Navigate also offers Zero Click Exam. The feature streamlines an x-ray technologist’s work through a barcode reader that matches a patient to an x-ray order and automatically selects individual patient settings, ensuring they receive the correct exam as scheduled. These workflow improvements operate in conjunction with others to eliminate up to 100 percent of user clicks. The system also features quicker processing and turnaround of images without affecting x-ray quality, producing images in under 10 seconds.

“The portability of AMX Navigate and its upgrades benefit Carilion’s staff and all our patients,” said Daniel Karolyi, M.D., senior vice president and chair of radiology administration for Carilion. “We’ll be able to more seamlessly deliver x-rays for critical care patients by more easily bringing the x-ray bedside, eliminating the need to move a patient to the hospital’s radiology department.”

“No one is more familiar with the ins and outs of X-ray imaging than technologists,” said Katelyn Nye, General Manager, Mobile X-ray and Artificial Intelligence, GE Healthcare. “That’s why we worked closely with them to design new features focused on removing the stress and strain of the technologist’s everyday workflow – from the positioning of a portable X-ray for an exam to its overall maneuverability from the Emergency Room to the Operating Room to the patient’s bedside. Already, the feedback has been overwhelmingly positive – with many X-ray technologists saying our new system addresses their core needs unlike ever before.”

 

Omicron Cousin BA.2 Spread Puts Scientists On High Alert

Omicron Cousin BA.2 Spread Puts Scientists On High Alert

Keypoints-

  • Scientists are now tracking 2 which is the close cousin of highly transmissible BA.1beginning to spread across Asia and Europe.
  • 2 cases are on the rise in Denmark, accounting for 82% of the total infections.
  • However, there are no signs of this sub variant skipping the vaccine protection as yet.
  • Preliminary analysis confirms BA.2 to be 1.5 times more contagious than BA.1.

Omicron, which is a highly transmissible variant from the SARS-CoV-2 family, is now featuring across all the infections globally as the cases continue to peak across some countries. Scientists now have another concern to worry about as they are now tracking cases caused by a close cousin, also known as BA.2, which has already begun to rise beyond BA.1 across parts of Asia as well as Europe.

There are the following elements that we know about this sub variant:

As reported by the WHO, notably, BA.1 has already accounted for almost 98.8% of the sequences that have been submitted to GISAID, which happens to be a public virus tracker database. The updated percentage was as recent as January 25. However, the pattern has begun to shift significantly as several countries have begun to report another sub variant, BA.2.

Besides BA.1 and BA.2, there are another couple of sub variants such as BA.1.1.529 and BA.3 that have come to light under the omicron umbrella. Although they all happen to be close knit genetically, each features mutations different from one another and therefore would alter their pattern.

Trevor Bedford, a computational virologist from Fred Hutchinson Cancer Center, has been in the process of tracing and tracking the evolution of SARS-CoV-2 and has written on his social media handle that BA.2 as on date represents somewhere around 82% of the cases across Denmark, 9% and 8% in the UK and the US respectively. This figure is based on his analysis of sequencing data from the database shared by GISAID as well as case counts from one of the projects of the University of Oxford. From what we know, the BA.1 sub variant of omicron is much easier to track as compared to its predecessors or the ones that have followed. This is solely because BA.1 happens to be the missing one of three target genes that are used across PCR tests. Cases which showcase this pattern are assumed to be by default caused by BA.1.

BA.2, which is also known as the stealth sub variant, is not accompanied by the same missing target gene, but the scientists are leaving no stone unturned in examining it in the same way as they did in the case of Delta, by tracking it through a number of virus genomes which have been submitted to GISAID. As it is possible in the case of other variants, BA.2 can also be detected by home kit tests used for coronavirus. However, it is impossible to predict which variant would be responsible.

Is It More Transmissible?

Well, the preliminary reports do suggest that BA.2 can be more contagious than the extremely transmissible BA.1. That said, there is no evidence thus far which suggests that it is likely to skip the vaccine protection.

According to the Danes, BA.2 is estimated to be one and a half times more contagious than BA.1, but it doesn’t cause any severe disease. For example, in England, an early analysis suggests that the contact tracing done between Dec 27 and Jan 11 puts more light on higher household transmission among carriers of BA.2 vis-a-vis the omicron cases.

The UK Health Security Agency hasn’t found any difference when it comes to the vaccine’s effectiveness. An infectious disease expert, Dr. Egon Ozen, from Chicago’s Northwestern University Fienberg School of Medicine, opines that the significant question as of now is whether the population infected by BA.1 would fall prey or be protected from BA.2. This has been a major cause of concern in Denmark, where some places that had high infections of BA.1 were reporting BA.2 cases as well.

Ozer adds that if BA.1 infection does not cause protection against BA.2, this could very well be the beginning of a humped camel wave, although it is too early to make a presumption on that. He goes on to say that the vaccines and the boosters will still keep people out of hospitals and even death.

Crosscope and BALCO Medical Centre Partner for More Effective Cancer Diagnosis via AI-enabled Digital Pathology Platform

Crosscope and BALCO Medical Centre Partner for More Effective Cancer Diagnosis via AI-enabled Digital Pathology Platform

Crosscope Inc, a Silicon Valley-based leader of AI-enabled Digital Pathology Software, and BALCO Medical Centre, flagship unit of Vedanta Medical Research Foundation (VMRF), are joining hands for the digital transformation of their pathology department. This collaboration will focus on using an AI-enabled Digital Pathology Platform from Crosscope, thereby, transforming analog histopathology workflow to AI-enabled digital workflow for the hospital.

Given the exponential rise of healthcare data volumes, healthcare providers are looking towards technology solutions that provide a complete 360-degree patient-centric view for the oncology care continuum. The past couple of years through the COVID-19 pandemic has pushed the operational limits for patient care and collaborations between healthcare organizations and technology solutions have become more important than ever. Hospitals and healthcare providers are quickly revamping & leveraging new technologies like the one offered by Crosscope to expedite their digital transformation plans.

With new cancer cases projected to rise by 70% within the next couple of decades, Crosscope is building a suite of technology solutions to usher innovation through cancer data-driven healthcare for accelerated and accurate cancer diagnosis for better patient outcomes. Crosscope, known for its expertise in deep learning-based computational pathology algorithms, will implement its AI enabled Digital Pathology platform Crosscope Dx, which provides a unified solution for the needs at BALCO Medical Centre.

“Effective deployment of Artificial Intelligence (AI) is the need of the hour in the healthcare sector. We anticipate digitization of pathology will result in improved workflow and most importantly, result in rapid and accurate diagnosis. These technological developments will enable faster, efficient, and affordable cancer care solutions for all”, said Chairperson of BALCO Medical Centre, Mrs. Jyoti Agarwal.

This partnership will lead to the deployment of Crosscope’s Digital Pathology platform to provide AI-based diagnostics support ensuring precision-based, time-bound cancer diagnosis, support collaboration, pathology workflows, and archiving of pathology images. “Indian healthcare is on the cusp of digital transformation and we, at Crosscope, are enabling healthcare providers with AI-assisted remote workflows for a pathology revolution. Our ultimate vision is to aid healthcare organizations with reduced turnaround time, improved diagnostic performance, global collaborations, and provide consistent and accurate care to patients in a timely manner” said Jayendra Shinde, Ph.D., the CEO of Crosscope.

BALCO Medical Centre is on a mission to provide affordable, world-class cancer care to all and offers ultra-modern, multi-modality diagnostic and therapeutic cancer treatment. “Microscopic examination of biopsies remains a daunting task and is the gold standard for diagnosis and staging of cancer. This type of AI-based solution platform, like Crosscope, is expected to lead to diagnostic and therapeutic precision and shorten the period between primary diagnosis and therapy”, said Dr. Sandeep Ojha, Consultant, Histopathology, BALCO Medical Centre.

With a multi-layered approach that involves digitization of data, deploying the end-to-end Digital Pathology solution, AI-enabled workflows, and integration, Crosscope is transforming the histology-driven cancer diagnostics landscape. “Digital transformation is a reality today and the effects of which can be seen in Crosscope’s AI-enabled vendor-agnostic Digital Pathology platform, which will allow a seamless transition from analog to digital with tools like AI-assisted triaging for efficient histopathology workload management and an integrated workflow solution that incorporates AI-assisted cancer detection tools for several tumor types ultimately assisting pathologists, cancer care providers in the region and around the world in early detection paving the way for precision medicine & early detection.” said Puneet Pantane, Chief Business Officer at Crosscope.

This collaboration between the two organizations will highlight how digitization & digital transformation in Pathology using AI, ML can bring change in the lives of cancer patients ensuring early diagnosis & helping pathologists to improve overall patient outcomes, decrease workload, reduce turnaround time drastically helping reduce the cancer disease burden for the region & the world.

About BALCO Medical Centre
BALCO Medical Centre, Vedanta Medical Research Foundation’s (VMRF) first flagship initiative setup in Naya Raipur, Chhattisgarh, is a 170-bed, state-of-the-art tertiary care oncology facility. With a robust medical team of more than 50 specialists, it provides affordable yet world-class treatment of cancer, the most critical disease known to mankind. BALCO Medical Centre has brought ultra-modern, multi-modality diagnostic and therapeutic facilities within easy reach of India’s population at a reasonable and affordable cost. Currently, it is fast emerging as a national leader in India’s oncology space including medical, surgical, radiation, haematological and palliative care.

Northeast TAC HealthCare Group Opens Seven-Figure Specialist Endoscopy Suite To Enable Ease Of Access To Patients

Northeast TAC HealthCare Group Opens Seven-Figure Specialist Endoscopy Suite To Enable Ease Of Access To Patients

Aberdeen-based TAC Healthcare Group announces that it has opened a specialist diagnostic endoscopy suite located at its Dyce headquarters in Aberdeen. Following a significant seven-figure investment, the purpose-built suite located at Wellheads Crescent will be the first carbon neutral endoscopy facility in Scotland. The suite adds valuable additional capacity to endoscopy services in NE Scotland.

Endoscopy is essential for detecting diseases such as polyps, Crohn’s Disease, ulcers and cancers but endoscopy services across the UK are under unprecedented pressure due to increased demand and also as a result, finding it difficult to provide these procedures during the COVID-19 pandemic. Currently around 34,500 patients in Scotland are waiting for an endoscopy test and over 2,500 patients have been waiting 39-52 weeks for this procedure*.

Speaking of the new endoscopy suite Ken Park, Clinical Director at TAC Healthcare Group, says, “The aim of our facility is to provide ease of access for patients requiring endoscopy, which is key to early diagnosis of a number of conditions in which early detection is the best way to ensure that treatment is effective. In other cases, this ease of access will also enable us to reassure others that there is no serious cause for the symptoms they have been worried about, which can ease anxiety and stress.”

Ken continues, “TAC’s approach to endoscopy is a departure from the traditional independent sector approach where endoscopy has been delivered along with a number of other procedures. Our endoscopy suite only undertakes endoscopy – we do this for both public and private patients and it means that we have specialist nurses and doctors undertaking large numbers of procedures. No one particularly looks forward to an endoscopy but having it done by a team that is doing it all the time is the best way to ensure the procedure is done well, quickly and with the minimum of upset. In addition, being a specialist unit, we have the most up to-date endoscopes and AI interpretation of images to support the clinicians performing the tests.”

Ken concludes, “We are all very aware of the impact that new buildings and services have on our environment so that although my primary goal is to provide our patients with access to the best service available, I’m also very proud that this is a zero-carbon unit.”

This is the second significant investment that the TAC Healthcare group has made following the announcement of a £2 million investment to equip and refurbish its state-of-the-art occupational health centre and expand its team in June 2021. Occupational health services are housed in a dedicated wing at the Dyce-headquartered building with access and infection control central to the design. This has enabled business continuity for the energy sector and other supported organisations throughout the pandemic.

5 Reasons To Become A Nurse

There are a few important things that you need to consider if you want to be a nurse. Becoming a nurse is a calling, not a job – so if you’re in it just for the paycheck.

Nurses, especially during pandemics, see more pain in a day than you’d wish on anyone in a lifetime. Yet, they joke, they talk about family, homework, food cravings and fantasy holidays. They sing along to the radio, and they hold your hand when you’re afraid. They give you secret winks when an unwanted tear finds its way to your lip, and make you smile again before you even taste the salt.

Nurses are remarkable and so good at lifting hearts. If you’re interested in pursuing a career in nursing, here are five excellent reasons to do so:

  1. Nurses Make A Difference

Imagine being able to help people and get paid for it? Being a nurse is not at all easy – there will be times when you will question why you didn’t choose an easier path for yourself. Those days, thankfully, are usually offset by helping someone who truly appreciates it.

If you have a passion for helping people and you’ve got an iron stomach, then nursing is for you.

  1. Job Security

Nursing will always be a stable career choice because there is a nursing shortage in almost every country in the world. Nurses face multiple issues throughout their careers, from long hours to a shortage of personal protective equipment like masks and coveralls.

This career path is not for the faint of heart and you will have a lot of responsibilities on your shoulders. The upside to all of that is that you have the opportunity to help people in any city of your choice.

  1. Overseas Opportunities

The nursing shortages faced by most countries has created a steady demand for these walking medical angels. There are so many opportunities out of the hospital for nurses, both locally and globally.

Get your nursing license as soon as you can so you can start to explore your options.

  1. Active Work

Nursing is one of the most active career choices – you will rarely have a still moment during your working day. Most nurses get their 10 000 steps in each day without any problems. To be a nurse, especially a good one, you need to understand that you will be on the move constantly.

Running after patients and doctors can be incredibly tiring, so make sure you have a great support system at home to help you juggle your work and personal life.

  1. Get A Job Quickly

So many people finish studying and struggle to find employment. Nursing is one of the careers that will always allow you to enter the workforce quickly. Most nurses are extremely satisfied with their career choices, but their jobs are not without an unfair share of daily struggles.

Being a nurse is a fantastic honour but be prepared to take the good with the bad. On the bright side, because of the pandemic, many countries have realised that there is a lot of work to be done in this field, and they are increasing their legislative budgets for healthcare and nursing.

Here’s to hoping that happens sooner rather than later; that way you can focus on helping people to heal.

Permanente Health Care Ventures and Datos Health Launch Breakthrough Covid 19 Remote Monitoring App to Ensure Back to Work Safety

Wales-based firm develops COVID-19 test companion app

Permanente Health Care Ventures (PHCV) and Datos Health (Datos) are pleased to announce the public launch of their turnkey self-service Sidney Navigator™ Covid 19 solution. This innovative monitoring platform is the product of a collaboration between PHCV and Datos.

Datos and PHCV came together at the beginning of the pandemic to respond to requests from employers and universities like Pacific University Oregon. Pacific University wanted a tool to help keep its population safe while continuing in-person learning. “We needed a solution to help us mitigate risk and monitor student and employee COVID protocol compliance across our system. Our main concern was to clearly guide exposed individuals, and those exhibiting symptoms, to appropriate next steps. As new mandates emerged, we needed a platform that could quickly and easily adjust,” explained Jennifer Yruegas, Dean College of Business and General Counsel of Pacific University Oregon.

The project soon evolved to capture symptoms, illnesses, and vaccine reactions. “Datos Health was the logical partner for this project because of its track record of high-quality care monitoring and adaptive technology infrastructure,” said Dr. Micah Thorp, DO, Vice President of Strategy, Northwest Permanente PC, and President, PHCV. “Based on guidance from infectious disease experts, we worked closely with Datos to interpret and maintain CDC-compliant workflows as they evolved.”

“We are uniquely positioned for projects such as this one because of our platform’s flexibility. Unlike other Remote Patient Monitoring (RPM) systems that incorporate pre-built workflows, we have no limitations on what can be monitored or automated,” said Uri Bettesh, CEO and Founder of Datos Health. “Our initial goal was to keep the workplace and campus populations safe. Now, the platform not only monitors health in relation to COVID, but also helps employers manage the status of each employee regarding vaccine administration and testing.”

PHCV’s high-frequency yet low-touch Sidney Navigator™ platform ensures employers are aware of employee population status in real-time. Built-in alerts encourage appropriate next steps are taken by employees and create a record of compliance for employers. Datos and PHCV will continue their partnership to ensure the Sidney Navigator™ Covid 19 solution remains the leading platform for employee compliance with COVID guidelines.

About Datos Health

Since 2015, Datos Health has supported the growing need to monitor and care for patients remotely with quick and easy deployment of personalized clinical workflows. Our solution facilitates automated assisted self-care across any clinical condition, patient profile, or treatment plans, significantly increasing patient engagement and reducing adverse events. The Datos Health platform replaces today’s rigid, pre-built RPM solutions with a powerful open framework. Providers gain unlimited freedom to adapt our out-of-the-box remote care programs to fit their workflows or they can easily design their own programs.?

About Permanente Health Care Ventures

Permanente Health Care Ventures (PHCV) drives innovation in the practice of medicine and the delivery of 21st century healthcare solutions. A subsidiary of Northwest Permanente, PC, the largest independent multi-specialty physician group in Oregon and SW Washington, PHCV is committed to advancing total health of the patients, people and communities they serve.

MDLIVE launches chronic condition monitoring program

Digital care firm MDLIVE is launching a health-monitoring program aimed toward sufferers with persistent circumstances.

The providing, accessible to well being plans that make the most of MDLIVE’s major care companies, permits sufferers to trace metrics like blood strain or glucose ranges so their medical doctors can assessment them throughout digital visits.

The telehealth firm plans so as to add units that may transmit these metrics on to MDLIVE’s affected person portal later this 12 months.

The CDC estimates six in 10 U.S. adults have a persistent illness like diabetes, coronary heart illness or COPD. Continual circumstances also drivers of the nation’s yearly healthcare expenditure.

MDLIVE positions its program as a technique to handle persistent circumstances extra successfully.

“Demand for digital major care has skyrocketed since we first launched it two years in the past, and this new growth permits us to raised serve a better variety of People dwelling with persistent circumstances, delivering higher well being outcomes and decrease prices that profit each sufferers and their well being plans,” chief medical officer Dr. Cynthia Zelis mentioned in an announcement.

“Our new well being monitoring program deepens the partnership between MDLIVE major care suppliers and sufferers, giving them better insights into the important each day well being information that may be an early indicator of a critical medical difficulty.”

MDLIVE was acquired by insurer Cigna’s well being companies subsidiary Evernorth final 12 months. In October, Cigna announced its enrollees in employee-sponsored plans would get entry to expanded lined telehealth companies through MDLIVE, and launched a virtual-first plan for choose employers.

Continual-care administration is a well-liked focus for digital well being and digital care firms. Late final 12 months, chronic-care-focused distant monitoring and telehealth platform Cadence scored $100 million in Sequence B funding.

Membership-based major care firm One Medical launched its own chronic-condition management providing in October, together with integration with remote-monitoring instruments, 24/7 digital assist and a multidisciplinary care staff.

Hybrid supplier Carbon Well being additionally stepped into chronic-disease administration final 12 months with its acquisition of diabetes care startup Steady Health.

Others within the house embrace Lyn Well being, which emerged from stealth in December; One Drop, which just lately revealed a product aimed toward preventing cardiovascular disease; and Sweetch, which announced a $20 million raise in July.

AccurKardia Announces Collaboration with MDF Instruments to Develop ECG Solutions for the Next Generation of Stethoscopes

AccurKardia Announces Collaboration with MDF Instruments to Develop ECG Solutions for the Next Generation of Stethoscopes

AccurKardia, Inc., a software company that provides clinical-grade, device agnostic, automated ECG analytics, announced a collaboration with MDF Instruments, a highly-regarded and longstanding medical supplier, to develop ECG (electrocardiogram) solutions for the next generation of stethoscopes. This collaboration brings together AccurKardia’s cutting edge innovation in device-agnostic, automated ECG analytics with clinical-grade accuracy and MDF Instruments’ more than 40 years of experience designing, manufacturing, and distributing premium diagnostic instruments.

Cardiovascular disease is the leading cause of death globally, accounting for approximately 18.6 million deaths in 20191. Early detection is critical and could mean the difference between life and death for thousands of at-risk patients. Together, AccurKardia and MDF Instruments will empower and equip physicians and healthcare workers with state-of-the-art, evidence-based ECG real-time analysis at the point of care.

“We are excited to partner with AccurKardia, a unique innovator in the ECG analytics domain, to define and implement new tools to empower clinicians at all stages of patient management to identify disease at its infancy,” said Darren Ting, CEO of MDF Instruments.

“We are honored to partner with MDF instruments, a leader in diagnostic instruments, with a unique understanding of the needs of healthcare professionals. Our companies share the goal of improving patient outcomes,” said Juan C. Jiménez, CEO of AccurKardia. “By enabling the next generation of stethoscopes with automated ECG analysis capabilities, early and actionable insight for intervention and treatment can be provided, and that will help save lives.”

About AccurKardia:
AccurKardia is a digital-first and software-only healthcare company focused on enabling a world in which a combination of smart devices, reliable and actionable data, and efficient clinical intervention can together improve medical outcomes and save lives. AccurKardia provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies.

About MDF Instruments:
MDF® Instruments has been crafting stethoscopes, and medical diagnostic instruments since 1971. With our passion, innovation and style transpired in our products, we are proud to be the official long-term supplier to well-known NGOs and world health organizations, as well as support many lesser known medical missions that are improving the lives of people around the world—one afflicted child, one struggling family, and one underserved neighborhood at a time. We are Crafting Wellness.

At Home COVID Tests Major US Issue As Hospitalisations Rise

At Home COVID Tests Major US Issue As Hospitalisations Rise

Key Points

  • At homerapid testing has been conspicuously absent from the US’ fight against COVID-19.
  • The Biden Administration confirms that at-home tests will be critical in getting the economy back on track.
  • Substantial steps have been taken by the White House to increase the supply and lower the cost of the OTC testing kits.

The US has been caught off-guard. The latest wave has exposed flaws in the approach when it comes to one of the most important tools in fighting the pandemic, at-home rapid tests. As per Kaiser Family Foundation’s Lindsey Dawson, the country is still struggling to get federal guidance on how to ensure testing becomes a regular part of everyone’s life.

She adds that when it comes to comparing the US with the UK, there is a huge difference as in the latter’s case, people over 11 years of age are advised to take a test 2 times a week. In the US, as per her, if everyone above 12 years of age is tested twice a day, the test numbers would reach 2.3 billion in a month, and that’s beyond the current possibility.

The White House has already made it very clear that over-the-counter test kits sold by drugstores are critical in order to keep the economy going in the current scenario where omicron has been a cause of concern and there may be a few other variants lined up. It’s no surprise that demand for at-home tests has already increased, given that January saw a surge in hospitalization, resulting in deliberate price inflation and supply constraints.

From what could be seen currently, the fight against the pandemic isn’t over and the home tests are poised to play a pivotal role in the central and state’s effort to lessen the onslaught of yet another pandemic-inflicted winter. The vaccination rate in the United States has not been increasing, leaving citizens vulnerable to the virus. Besides, kids under five still long for access to any approved dose.

Vaccinated Americans are also facing the virus’ heat, and researchers are trying to gauge the reasons for it. As per the Kaiser Family Foundation, FDA’s federal regulators have been in the eye of the storm for taking time to authorise the at-home COVID tests. Not only that, the CDC, with its evolving testing guidance for people who are vaccinated, has already left test manufacturers confused.

Translate »